Novel asymmetric photosensitizers: An in vitro study

Cancer Letters

Volumn 105, Issue 2, 1996, Pages 187-193

  Haylett, Ann K ^a   Forbes, Ethel ^b   MacLennan, Alex ^b   Truscott, T George ^c   Moore, James V ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

Author keywords

Clonogenic assay; Melanoma; Novel photosensitizers; Photodynamic therapy

Indexed keywords

ALKYL GROUP; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG UPTAKE; HUMAN; HUMAN CELL; PARTITION COEFFICIENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030565014     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04279-6     Document Type: Article

References (21)

1. [1] Bohmer, R.M. and Morstyn, G. (1985) Uptake of haematoporphyrin derivative by normal and malignant cells: effect of serum, pH, temperature and cell size. Cancer Res., 45, 5328-5334.
2. [2] Darmanyan, A.P. and Foote, C.S. (1992) Effect of sensitizer heavy atoms on singlet oxygen generation efficiency. J. Phys. Chem., 96, 3723-3728.
3. [3] Davis, S., Weiss, M.J., Wong, J.R., Lampidis, T.J. and Chen, L.B. (1985) Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem., 260, 13844-13850.
4. [4] Detty, M.R., Merkel, P.B., Hilf, R., Gibson, S.L. and Powers, S.K. (1990) Chalcogenapyrylium dyes as photochemotherapeutic agents, 2: tumor uptake mitochondrial targeting and singlet oxygen-induced inhibition of cytochrome c oxidase. J. Med. Chem., 33, 1108-1116.
5. [5] Dougherty, T.J. and Marcus, S.L. (1992) Photodynamic therapy. Eur. J. Cancer, 28A, 1734-1742.
6. [6] Gomer, C.J. (1989) Photodynamic therapy in the treatment of malignancies. Semin. Hematol., 26, 27-34.
7. [7] Gomer, C.J. (1991) Preclinical examination of first and second generation protosensitizers used in photodynamic therapy. Photochem. Photobiol., 54, 1093-1107.
8. [8] Gomer, C.J., Doiron, D.R., Rucker, N., Razum, N.J. and Fountain, S.W. (1984) Action spectrum (620-640 nm) for hematoporphyrin derivative induced cell killing. Photochem. Photobiol., 39, 365-368.
9. [9] Haylett, A.K., Ross, S., Truscott, T.G. and Moore, J.V. (1995) Pharmacokinetic and therapeutic outcome in melanoma cells, of the administration of symmetric and asymmetric cationic photosensitizers. Cancer Lett., 88, 191-199.
10. [10] Jori, G. (1989) In vivo transport and pharmacokinetic behaviour of tumour photosensitizers. In: Ciba Foundation Symposium 146, pp. 78-86. Wiley, Chichester, UK.
11. [11] Jori, G., Beltramini, M., Reddi, E., Salvato, B., Pagnan, A., Ziron, L., Tomio, L. and Tsanov, T. (1984) Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett., 24, 291-297.
12. [12] Lin, C.W., Shulok, J.R., Kirley, S.D., Cincotta, L. and Foley, J.W. (1991) Lysosomal localization and mechanism of uptake of nile blue photosensitizers in tumour cells. Cancer Res., 51, 2710-2719.
13. [13] Maziere, J.C., Morliere, P. and Santus, R. (1991) The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J. Photochem. Photobiol. B, 8, 351-360.
14. [14] Maziere, J.C., Santus, R., Morliere, P., Refytmann, J.-P., Candide, C., Mora, L., Salmon, S., Maziere, C., Gatt, S. and Dubertret, L. (1990) Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins. J. Photochem. Photobiol. B, 6, 61-68.
15. [15] Moan, J., Peng, Q., Evensen, J.F., Berg, K., Western, A. and Rimington, C. (1987) Photosensitizing efficiencies tumor and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem. Photobiol., 46, 713-721.
16. [16] Oseroff, A.R., Ara, G., Ohouha, D., Aprille, J., Bommer, J.C., Yarmush, M.L., Foley, J. and Cincotta, L. (1987) Strategies for selective cancer photochemotherapy: anti-body-targeted and selective carcinoma cell photolysis. Photochem. Photobiol., 46, 83-96.
17. [17] Richelli, F. and Jori, G. (1990) Factors influencing the distribution pattern of porphyrins in cell membranes. J. Photochem. Photobiol. B, 6, 69-77.
18. [18] Shea, C.R., Sherwood, M.E., Flotte, T.J., Chen, N., Scholz, M. and Hasan, T. (1990) Rhodamine 123 phototoxicity in laser-irradiated MGH-U1 human carcinoma cells studied in vitro by electron microscopy and confocal laser scanning microscopy. Cancer Res., 50, 4167-4172.
19. [19] Wohrle, D., Iskander, N., Graschew, G., Sinn, H., Friedrich, E.A., Maier-Borst, W., Stern, J. and Schlag, P. (1990) Synthesis of positively charged pthalocyanines. Photochem. Photobiol., 51, 351-356.
20. [20] Woodburn, K.W., Vardaxis, N.J., Hill, J.S., Kaye, A.M., Reiss, J.A. and Phillips, D.R. (1992) Evaluation of porphyrin characteristics required for PDT. Photochem. Photobiol., 55, 697-704.
21. [21] Woodburn, K.W., Bellinger, G.C.A., Phillips, D.R. and Reiss, J.A. (1992) Synthesis of porphyrins derived from the amidation of protoporphyrin IX for use as potential chemotherapeutic agents. Aust. J. Chem., 45, 1745-1751.